AMERISAFE (AMSF) Earnings Analysis
AMERISAFE (AMSF) next reports earnings on 2026-11-04, consensus EPS 0.52 USD. Last quarter (2026-07-21) it missed with EPS 0.44 USD vs 0.517 USD est (-14.9%). It has beaten estimates in 1/6 recent quarters (17%). Trailing P/E 12.46.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AMSF next report earnings?
| Next earnings date | 2026-11-04 |
|---|---|
| Consensus EPS estimate | 0.52 USD |
| Revenue estimate | 0.08B |
AMSF earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-21 | 0.44 USD | 0.517 USD | -14.9% | Miss |
| 2026-04-22 | 0.5 USD | 0.543 USD | -7.9% | Miss |
| 2026-02-25 | 0.51 USD | 0.57 USD | -10.5% | Miss |
| 2025-07-24 | 0.53 USD | 0.55 USD | -3.6% | Miss |
| 2025-02-26 | 0.67 USD | 0.6 USD | +11.7% | Beat |
| 2024-07-29 | 0.58 USD | 0.63 USD | -7.9% | Miss |
Beat rate: 1/6 (17%) over reported quarters with consensus data.
AMSF valuation and analyst view
| Trailing P/E | 12.46 |
|---|---|
| Trailing EPS | 2.516 USD |
| Price / book | 0.52 |
| Dividend yield | 8.35% |
| Market cap | 0.60B |
| Analyst consensus | Buy (3 buy / 3 hold / 0 sell) |
| Avg price target | 32 USD |
Related research pages
Frequently asked questions
When is AMERISAFE (AMSF)'s next earnings date?
AMERISAFE is next scheduled to report on 2026-11-04, with a consensus EPS estimate of 0.52 USD and revenue estimate of 0.08B.
Did AMSF beat earnings last quarter?
In its 2026-07-21 report, AMSF posted EPS of 0.44 USD versus a 0.517 USD estimate — a miss of 14.9%.
What is AMSF's earnings track record?
Over the last 6 reported quarters with consensus data, AMSF beat estimates 1 times (17%).
What is AMSF's current P/E ratio and EPS?
AMSF trades at a trailing P/E of 12.46 on trailing EPS of 2.516495873902351 USD.
What do analysts rate AMSF?
Analyst consensus is "Buy" across 6 ratings (0 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 32 USD.